J. Matthew Hutzler, Ph.D. | February 10, 2016

Challenges and Opportunities with Aldehyde Oxidase

Q2 Solutions offers complete bioanalytical and ADME solutions for testing around the globe and across the product development spectrum.  We combine knowledge from the collective services provided by our central labs, bioanalytical and ADME labs network, as well as integration into Quintiles global early clinical Phase I unit.  Presented at the 2015 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting, this presentation details the challenges and opportunities with aldehyde oxidase, such as accurately predicting human clearance. Download now to learn more.

J Matthew Hutzler, Ph.D, Director of In Vitro Metabolism, Bioanalytical and ADME Labs

Related Services:
ADME Services

Accelerating your drug discovery, preclinical and clinical programs with ADME services

In Vitro ADME & Metabolite Identification Services List

Services to support your In Vitro ADME development needs

Metabolite Profile Comparison Using a HμREL Co-culture Hepatocyte Model versus a Conventional Hepatocyte Suspension for Low Turnover Drugs

Determining whether the HμREL model could produce metabolites consistent with those observed in previous human clinical studies

Read More